Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation
Open Access
- 18 May 2015
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 50 (8) , 1138-1140
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO studyBlood, 2012
- Peripheral Blood Lymphocyte and Monocyte Recovery and Survival in Acute Leukemia Postmyeloablative Allogeneic Hematopoietic Stem Cell TransplantTransplantation and Cellular Therapy, 2012
- Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaHaematologica, 2011
- The EBMT risk scoreBone Marrow Transplantation, 2011
- Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasiaLeukemia, 2011
- Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantationBlood, 2011
- Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic MalignanciesTransplantation and Cellular Therapy, 2010
- Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) in Single and Multiple Institutions: Limitations and InferencesTransplantation and Cellular Therapy, 2009
- Performance Status and Comorbidity Predict Transplant-Related Mortality After Allogeneic Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2006
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005